Addiction in developmental perspective: Influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence

Journal of Addictive Diseases

Volumn 31, Issue 1, 2012, Pages 45-59

  Carpentier, Pieter Jan ^a,d   Knapen, Lieke J M ^a   Van Gogh, Mijke T ^a   Buitelaar, Jan K ^b   De Jong, Cornelis A J ^c  

^a Novadic Kentron   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c Nijmegen Institute for Scientist Practitioners in Addiction NISPA   (Netherlands)

^d Reinier Van Arkel Groep   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Conduct disorder; Psychiatric comorbidity; Substance use disorder

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONDUCT DISORDER; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; RETROSPECTIVE STUDY;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CONDUCT DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84858147773     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.642756     Document Type: Article

References (62)

1. Connor DF. Disruptive behavior disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock's comprehensive textbook of psychiatry. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2009:3580-3596.
2. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 2003; 60(7):709-17. (Pubitemid 36818633)
3. Hill J. Early identification of individuals at risk for antisocial personality disorder. Br J Psychiatry 2003; 44(Suppl):S11-4. (Pubitemid 36071902)
4. Lahey BB, Loeber R, Burke JD, Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. J Consult Clin Psychol 2005; 73(3):389-9.
5. Odgers CL, Caspi A, Broadbent JM, et al. Prediction of differential adult health burden by conduct problem subtypes in males. Arch Gen Psychiatry 2007; 64(4):476-84. (Pubitemid 46556465)
6. Maughan B, Kim-Cohen J. Continuities between childhood and adult life. Br J Psychiatry 2005; 187:301-3. (Pubitemid 41442378)
7. Moffitt TE, Caspi A, Harrington H, Milne BJ. Males on the life-course-persistent and adolescence-limited antisocial pathways: follow-up at age 26 years. Dev Psychopathol 2002; 14(1):179-207. (Pubitemid 351690114)
8. Barker ED, Oliver BR, Maughan B. Co-occurring problems of early onset persistent, childhood limited, and adolescent onset conduct problem youth. J Child Psychol Psychiatry 2010; 51(11):1217-26.
9. Moffitt TE, Caspi A. Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Dev Psychopathol 2001; 13(2):355-75.
10. Knop J, Penick EC, Nickel EJ, et al. Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40. J Stud Alcohol Drugs 2009; 70(2):169-77.
11. Sartor CE, Lynskey MT, Heath AC, Jacob T, True W. The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence. Addiction 2007; 102(2):216-25. (Pubitemid 46096282)
12. Couwenbergh C, van den Brink W, Zwart K, Vreugdenhil C, van Wijngaarden- Cremers P, van der Gaag RJ. Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. Eur Child Adolesc Psychiatry 2006; 15(6):319-28. (Pubitemid 44306139)
13. Nock MK, Kazdin AE, Hiripi E, Kessler RC. Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication. Psychol Med 2006; 36(5):699-710.
14. Marmorstein NR, Iacono WG, McGue M. Alcohol and illicit drug dependence among parents: associations with offspring externalizing disorders. Psychol Med 2009; 39(1):149-55.
15. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160(6):1041-52. (Pubitemid 41070962)
16. McGue M, Iacono WG, Legrand LN, Malone S, Elkins I. Origins and consequences of age at first drink. I. Associations with substance-use disorders, disinhibitory behavior and psychopathology, and P3 amplitude. Alcohol Clin Exp Res 2001; 25(8):1156-65. (Pubitemid 32758467)
17. Lynam DR. Early identification of chronic offenders: who is the fledgling psychopath? Psychol Bull 1996; 120(2):209-34. (Pubitemid 126690071)
18. Johansson P, Kerr M, Andershed H. Linking adult psychopathy with childhood hyperactivity-impulsivity-attention problems and conduct problems through retrospective self-reports. J Pers Disord 2005; 19(1):94-101. (Pubitemid 40397366)
19. Soderstrom H, Sjodin AK, Carlstedt A, Forsman A. Adult psychopathic personality with childhood-onset hyperactivity and conduct disorder: a central problem constellation in forensic psychiatry. Psychiatry Res 2004; 121(3):271-80. (Pubitemid 37522180)
20. Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 1997; 36(8):1065-79. (Pubitemid 27337657)
21. Loeber R, Burke JD, Lahey BB, Winters A, Zera M. Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry 2000; 39(12):1468-84.
22. Roy A. The relationships between attention -deficit/hyperactive disorder (ADHD), conduct disorder (conduct disorder) and problematic drug use (PDU). Drugs 2008; 15(1):55-75.
23. Brook DW, Brook JS, Zhang C, Koppel J. Association between attentiondeficit/ hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch Pediatr Adolesc Med 2010; 164(10):930-4.
24. Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64(10):1145-52. (Pubitemid 47529338)
25. Marshal MP, Molina BS. Antisocial behaviors moderate the deviant peer pathway to substance use in children with ADHD. J Clin Child Adolesc Psychol 2006; 35(2):216-26. (Pubitemid 43723177)
26. Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005; 24(5):411-8. (Pubitemid 43024040)
27. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatmentseeking opioid abusers. Arch Gen Psychiatry 1997; 54(1):71-80. (Pubitemid 27044701)
28. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000; 176:285-9. (Pubitemid 30179850)
29. Carpentier PJ, Krabbe PF, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Psychiatric comorbidity reduces quality of life in chronicmethadonemaintained patients. Am J Addict 2009; 18(6):470-80.
30. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000; 61(4):244-51. (Pubitemid 30305365)
31. Modestin J, Matutat B, Wurmle O. Antecedents of opioid dependence and personality disorder: attention-deficit/hyperactivity disorder and conduct disorder. Eur Arch Psychiatry Clin Neurosci 2001; 251(1):42-7. (Pubitemid 32267315)
32. Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend 1994; 34(3):253-7. (Pubitemid 24091672)
33. Compton WM III, Cottler LB, Ben AA, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict 2000; 9(2):113-25. (Pubitemid 30419109)
34. Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004; 74(1):77-83. (Pubitemid 38457056)
35. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998; 52(1):15-25. (Pubitemid 28448698)
36. Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M. Attentiondeficit/ hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse 1999; 25(3):441-8. (Pubitemid 29395139)
37. King VL, Brooner RK, KidorfMS, Stoller KB, Mirsky AF. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999; 187(8):487-95. (Pubitemid 29422603)
38. Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2010; 17(1):10-20.
39. Robins LN, Cottler L, Bucholz K, Compton W. The diagnostic interview schedule, version IV. St. Louis, MO: Washington University, 1995.
40. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV personality disorders. Washington, DC: American Psychiatric Press, 1997.
41. Damen KF, De Jong CA, Van der Kroft PJ. Interrater reliability of the structured interview for DSM-IV personality in an opioiddependent patient sample. Eur Addict Res 2004; 10(3):99-104. (Pubitemid 39070097)
42. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168(1):26-33. (Pubitemid 10187569)
43. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20):22-33. (Pubitemid 29001829)
44. Cottler LB, Robins LN, Helzer JE. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict 1989; 84(7):801-14. (Pubitemid 19182559)
45. Kooij JJ. ADHD bij volwassenen. Inleiding in diagnostiek en behandeling. 1st ed. Lisse, The Netherlands: Swets & Zeitlinger, 2002.
46. Kooij JJ, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 2004; 34(6):973-82. (Pubitemid 39199967)
47. Kooij JJ, Marije BA, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 2008; 11(4): 445-58.
48. Arias AJ, Gelernter J, Chan G, et al. Correlates of co-occurring ADHD in drugdependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008; 33(9):1199-207.
49. Flory K, Milich R, Lynam DR, Leukefeld C, Clayton R. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/ hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav 2003; 17(2):151 -8.
50. Flory K, Lynam DR. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play? Clin Child Fam Psychol Rev 2003; 6(1):1-16. (Pubitemid 38979779)
51. Fergusson DM, Horwood LJ, Ridder EM. Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend 2007; 88 (Suppl 1):S14-26. (Pubitemid 46282352)
52. Wilens TE, Kwon A, Tanguay S, et al. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005; 14(4):319-27. (Pubitemid 41318270)
53. Schubiner H, Saules KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidatein the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002; 10(3):286-94. (Pubitemid 34919937)
54. Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005; 100(12):1868-74. (Pubitemid 41775212)
55. Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006; 81(2):137-48. (Pubitemid 41821797)
56. Levin FR, Evans SM, Brooks DJ, Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: doubleblind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007; 87(1):20-9. (Pubitemid 46074379)
57. Konstenius M, Jayaram-Lindstrom N, Beck O, Franck J. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend 2010; 108(1-2):130-3.
58. Markon KE, Krueger RF. Categorical and continuous models of liability to externalizing disorders: a direct comparison in NESARC. Arch Gen Psychiatry 2005; 62(12):1352-9. (Pubitemid 41746612)
59. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry 2004; 56(10):730-7. (Pubitemid 39539830)
60. Copeland WE, Shanahan L, Costello EJ, Angold A. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 2009; 66(7):764-72.
61. Reef J, Diamantopoulou S, van Meurs I, Verhulst F, van der Ende J. Child to adult continuities of psychopathology: a 24-year follow-up. Acta Psychiatr Scand 2009; 120(3):230-8.
62. Hicks BM, South SC, Dirago AC, Iacono WG, McGue M. Environmental adversity and increasing genetic risk for externalizing disorders. Arch Gen Psychiatry 2009; 66(6):640-8.